RESEARCH TRIANGLE PARK, N.C. – Jacques van Kimmenaede, a longtime executive with Organon Biosciences, is the new president of Diosynth Biotechnology.

Diosynth is part of NV Organon Biosciences, providing third-party contract manufacturing for biopharmaceuticals. Organon is based in the Netherlands.

The firm is part of Azko Nobel, which plans to spin off Organon as a separate company this year. Organon operates seven centers worldwide.

The two companies began a merger process in January of 2005.

Van Kimmenaede has worked for Organon since 1986, holding managerial positions in the United Kingdom, the Netherlands and also in New Jersey.